Shouyao Holdings (Beijing) Co. Ltd. A - Asset Resilience Ratio
Shouyao Holdings (Beijing) Co. Ltd. A (688197) has an Asset Resilience Ratio of 79.48% as of June 2025. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing. Read 688197 total debt and obligations for a breakdown of total debt and financial obligations.
Liquid Assets
Total Assets
Resilience Assessment
Asset Resilience Ratio Trend (2019–2024)
This chart shows how Shouyao Holdings (Beijing) Co. Ltd. A's Asset Resilience Ratio has changed over time. See net assets of Shouyao Holdings (Beijing) Co. Ltd. A for net asset value and shareholders' equity analysis.
Liquid Assets Composition Over Time
This chart breaks down Shouyao Holdings (Beijing) Co. Ltd. A's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time. For market capitalisation and broader financial context, see 688197 stock market capitalisation.
Current Liquid Assets Breakdown
| Component | Amount | % of Total Assets |
|---|---|---|
| Cash & Equivalents | CN¥0.00 | 0% |
| Short-term Investments | CN¥651.30 Million | 79.48% |
| Total Liquid Assets | CN¥651.30 Million | 79.48% |
Asset Resilience Insights
- Very High Liquidity: Shouyao Holdings (Beijing) Co. Ltd. A maintains exceptional liquid asset reserves at 79.48% of total assets.
- This level provides strong protection against economic uncertainties but may indicate potential for more aggressive growth investments.
- The company has significant short-term investments, indicating active treasury management.
Shouyao Holdings (Beijing) Co. Ltd. A Industry Peers by Asset Resilience Ratio
Compare Shouyao Holdings (Beijing) Co. Ltd. A's asset resilience ratio with other companies in the same industry.
| Company | Industry | Asset Resilience Ratio |
|---|---|---|
|
Royalty Pharma Plc
NASDAQ:RPRX |
Biotechnology | 0.10% |
|
Tubize-Fin
BR:TUB |
Biotechnology | 0.05% |
|
Shanghai Allist Pharmaceuticals Co. Ltd. A
SHG:688578 |
Biotechnology | 30.29% |
|
Hebei Changshan Biochem Pharma
SHE:300255 |
Biotechnology | -0.03% |
|
Shanghai RAAS Blood Products Co Ltd Class A
SHE:002252 |
Biotechnology | 4.52% |
|
Shanghai Junshi Biosciences Co Ltd
SHG:688180 |
Biotechnology | 4.28% |
|
Spyre Therapeutics Inc.
NASDAQ:SYRE |
Biotechnology | 83.49% |
|
Soleno Therapeutics Inc
NASDAQ:SLNO |
Biotechnology | 41.74% |
Annual Asset Resilience Ratio for Shouyao Holdings (Beijing) Co. Ltd. A (2019–2024)
The table below shows the annual Asset Resilience Ratio data for Shouyao Holdings (Beijing) Co. Ltd. A.
| Year | Asset Resilience Ratio (%) | Liquid Assets | Total Assets | Change |
|---|---|---|---|---|
| 2024-12-31 | 79.96% | CN¥737.41 Million ≈ $107.91 Million |
CN¥922.23 Million ≈ $134.95 Million |
+70.95pp |
| 2023-12-31 | 9.00% | CN¥100.14 Million ≈ $14.65 Million |
CN¥1.11 Billion ≈ $162.74 Million |
-13.94pp |
| 2019-12-31 | 22.94% | CN¥50.21 Million ≈ $7.35 Million |
CN¥218.89 Million ≈ $32.03 Million |
-- |
About Shouyao Holdings (Beijing) Co. Ltd. A
Shouyao Holdings (Beijing) Co., LTD. engages in the research, development, and production of innovative drugs in China. The company offers drugs for various indications, including non-small cell lung cancer, lymphoma, hepatocellular carcinoma, pancreatic cancer, breast cancer, ovarian cancer, thyroid cancer, leukemia, and diabetes. The company was founded in 2016 and is headquartered in Beijing, … Read more